Shao-Ming Wang1,2, Neal D Freedman2, Hormuzd A Katki3, Charles Matthews2, Barry I Graubard3, Lisa L Kahle4, Christian C Abnet2. 1. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 2. Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. 3. Biostatistics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 4. Information Management Services Inc, Calverton, Maryland.
Abstract
BACKGROUND: Prior studies have suggested that gastroesophageal reflux disease (GERD) may be associated with risk of squamous cancers of the larynx and esophagus; however, most of these studies have had methodological limitations or insufficient control for potential confounders. METHODS: We prospectively examined the association between GERD and esophageal adenocarcinoma (EADC), esophageal squamous cell carcinoma (ESCC), and laryngeal squamous cell carcinoma (LSCC) in 490,605 participants of the NIH-AARP Diet and Health Study cohort who were 50-71 years of age at baseline. Exposure to risk factors were obtained from the baseline questionnaire. GERD diagnosis was extracted among eligible participants via linkage to Medicare diagnoses codes and then multiply imputed for non-Medicare-eligible participants. Hazard ratios (HRs) and 95% CIs of GERD were computed using Cox regression. RESULTS: From 1995 to 2011, we accrued 931 cases of EADC, 876 cases of LSCC, and 301 cases of ESCC in this cohort and estimated multivariable-adjusted HRs of 2.23 (95% CI, 1.72-2.90), 1.91 (95% CI, 1.24-2.94), and 1.99 (95% CI, 1.39-2.84) for EADC, LSCC, and ESCC, respectively. The associations were independent of sex, smoking status, alcohol intake, and follow-up time periods. We estimated that among the general population in the United States, 22.04% of people aged 50-71 years suffered from GERD. Using risk factor distributions for the United States from national survey data, 16.92% of LSCC cases and 17.32% of ESCC cases among individuals aged 50-71 years were estimated to be associated with GERD. CONCLUSION: GERD is a common gastrointestinal disorder, but future prospective studies are needed to replicate our findings. If replicated, they may inform clinical surveillance of GERD patients and suggest new avenues for prevention of these malignancies.
BACKGROUND: Prior studies have suggested that gastroesophageal reflux disease (GERD) may be associated with risk of squamous cancers of the larynx and esophagus; however, most of these studies have had methodological limitations or insufficient control for potential confounders. METHODS: We prospectively examined the association between GERD and esophageal adenocarcinoma (EADC), esophageal squamous cell carcinoma (ESCC), and laryngeal squamous cell carcinoma (LSCC) in 490,605 participants of the NIH-AARP Diet and Health Study cohort who were 50-71 years of age at baseline. Exposure to risk factors were obtained from the baseline questionnaire. GERD diagnosis was extracted among eligible participants via linkage to Medicare diagnoses codes and then multiply imputed for non-Medicare-eligible participants. Hazard ratios (HRs) and 95% CIs of GERD were computed using Cox regression. RESULTS: From 1995 to 2011, we accrued 931 cases of EADC, 876 cases of LSCC, and 301 cases of ESCC in this cohort and estimated multivariable-adjusted HRs of 2.23 (95% CI, 1.72-2.90), 1.91 (95% CI, 1.24-2.94), and 1.99 (95% CI, 1.39-2.84) for EADC, LSCC, and ESCC, respectively. The associations were independent of sex, smoking status, alcohol intake, and follow-up time periods. We estimated that among the general population in the United States, 22.04% of people aged 50-71 years suffered from GERD. Using risk factor distributions for the United States from national survey data, 16.92% of LSCC cases and 17.32% of ESCC cases among individuals aged 50-71 years were estimated to be associated with GERD. CONCLUSION: GERD is a common gastrointestinal disorder, but future prospective studies are needed to replicate our findings. If replicated, they may inform clinical surveillance of GERD patients and suggest new avenues for prevention of these malignancies.
Authors: A F Subar; D Midthune; M Kulldorff; C C Brown; F E Thompson; V Kipnis; A Schatzkin Journal: Am J Epidemiol Date: 2000-08-01 Impact factor: 4.897
Authors: Nikki Johnston; David Bulmer; Gulnaz A Gill; Marguerite Panetti; Peter E Ross; Jeffrey P Pearson; Massimo Pignatelli; Sophie E Axford; Peter W Dettmar; James A Koufman Journal: Ann Otol Rhinol Laryngol Date: 2003-06 Impact factor: 1.547
Authors: David O Francis; Charles Maynard; Ernest A Weymuller; Gayle Reiber; Albert L Merati; Bevan Yueh Journal: Laryngoscope Date: 2011-01 Impact factor: 3.325
Authors: Adrian Săftoiu; Cesare Hassan; Miguel Areia; Manoop S Bhutani; Raf Bisschops; Erwan Bories; Irina M Cazacu; Evelien Dekker; Pierre H Deprez; Stephen P Pereira; Carlo Senore; Riccardo Capocaccia; Giulio Antonelli; Jeanin van Hooft; Helmut Messmann; Peter D Siersema; Mario Dinis-Ribeiro; Thierry Ponchon Journal: Endoscopy Date: 2020-02-12 Impact factor: 10.093
Authors: Scott M Langevin; Dominique S Michaud; Carmen J Marsit; Heather H Nelson; Ariel E Birnbaum; Melissa Eliot; Brock C Christensen; Michael D McClean; Karl T Kelsey Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05-23 Impact factor: 4.254
Authors: Shao-Ming Wang; Hormuzd A Katki; Barry I Graubard; Lisa L Kahle; Anil Chaturvedi; Charles E Matthews; Neal D Freedman; Christian C Abnet Journal: Am J Gastroenterol Date: 2021-09-01 Impact factor: 12.045